Out now … JNM podcast edition #10. All you need to know about metabolic PET biomarkers beyond SUVmean and SUVmax. @IreneBuvat @JournalofNucMed @SNM_MI @CzerninJohannes youtube.com/watch?v=paszMI…
Ken Herrmann
@ProfKHerrmann
Nuc Med - Theranostics - Innovation. Embracing Change.
300 Following 1.3K Followers 709 Posts
Latest posts 5
Very insightful discussion with a lot of learning points for me !
Advancing tomorrow’s cancer medicines: Jacob Van Naarden Talks with Ken Herrmann and Johannes Czernin about corporate approaches to new therapeutics development. ow.ly/fHeF50Vgag5
#RPTherapy #NuclearMedicine #Cancer @ProfKHerrmann @CzerninJohannesView quoted post on X
Kicking off the inaugural edition of APCCC Diagnostics with two NEJM first authors … @veerukasi Prof. Jonas Hugosson. More to come over the next days. @APCCC_Lugano @stefanofanti4 @LoebStacy @Silke_Gillessen @DrMHofman @DrSpratticus @TylerSbrt @ProfHadaschik
The next big thing in nuclear medicine diagnostics: next generation cardiovascular imaging. Check out the new JNM podcast with the giants of cardiovascular imaging: Frank Bengel Sharmila Dorbala Jamshid Maddahi. @JournalofNucMed youtube.com/watch?v=4IVasq…
Just out: An interview with Jacob van Naarden on his (and Lilly’s) views of radiotheranostics. @CzerninJohannes @JournalofNucMed @SNM_MI jnm.snmjournals.org/content/early/…
jnm.snmjournals.org Advancing Tomorrow’s Cancer Medicines Ken Herrmann, MD, MBA, from the Universitätsklinikum Essen (Germany), and Johannes Czernin, MD, from the David Geffen School of Medicine at the UCLA, talked with Jacob S. Van Naarden, executive vice...